Under the direction of Executive Director Walter J. Curran, Jr., MD, Winship has continued to enhance its administrative team and its functionality through process improvements, staff restructuring, and growth. Senior Director for Cancer Research Administration Kimberly Kerstann, PhD oversees Winship Administration. Kerstann sets the Winship administrative priorities to facilitate the strategic advancement of collaborative cancer- related research in a matrix organization. Winship Administration assists the Executive Director, senior leadership, program leaders and co-leaders, shared resource directors, and members in fulfilling the mission of Winship by offering highly effective administrative management, program planning, and centralized services. The administrative unit supports faculty and staff involved with the CCSG and its related activities, occupants of Winship space, recipients of Winship pilot grants and philanthropic funds, participants in cancer disease site working groups and programs, and participants in clinical oncology investigation. Winship Administration has continued to seek guidance from internal and external advisors and act strategically to position itself for growth. Winship?s senior leadership team is comprised of Executive Director Walter J. Curran, Jr., MD; Deputy Director Suresh Ramalingam, MD; Associate Director for Population Sciences Carla Berg, PhD; Associate Director for Mentorship, Education, and Training Deborah Bruner, PhD, RN; Associate Director for Basic Science Paul Doetsch, PhD; Associate Director for Clinical Research Bassel El-Rayes, MD; and Senior Director for Cancer Research Administration Kimberly Kerstann, PhD. Senior leadership oversees the advancement of Winship?s scientific priorities, Winship?s research programs and shared resources, Winship?s education, training, and mentorship efforts, Winship?s multi-investigator, multi-disciplinary, and translational science, and its cancer- related clinical research. Senior leadership is also responsible for developing and executing Winship?s strategic planning process.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA138292-09
Application #
9280108
Study Section
Subcommittee A - Cancer Centers (NCI-A)
Project Start
Project End
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
9
Fiscal Year
2017
Total Cost
$515,670
Indirect Cost
$186,299
Name
Emory University
Department
Type
Domestic Higher Education
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Richardson, Alessandra M; Havel, Lauren S; Koyen, Allyson E et al. (2018) Vimentin Is Required for Lung Adenocarcinoma Metastasis via Heterotypic Tumor Cell-Cancer-Associated Fibroblast Interactions during Collective Invasion. Clin Cancer Res 24:420-432
Goldstein, Jordan S; Nastoupil, Loretta J; Han, Xuesong et al. (2018) Disparities in survival by insurance status in follicular lymphoma. Blood 132:1159-1166
Guidot, Daniel M; Switchenko, Jeffrey M; Nastoupil, Loretta J et al. (2018) Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility. Leuk Lymphoma 59:888-895
Jin, Lingtao; Chun, Jaemoo; Pan, Chaoyun et al. (2018) MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation. Cancer Cell 34:315-330.e7
Chowdhary, Mudit; Okwan-Duodu, Derick; Switchenko, Jeffrey M et al. (2018) Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery. J Neurooncol 136:289-298
Chen, Zhengjia; Zheng, Youyun; Wang, Zhibo et al. (2018) Interactive calculator for operating characteristics of phase I cancer clinical trials using standard 3+3 designs. Contemp Clin Trials Commun 12:145-153
Halani, Sameer H; Yousefi, Safoora; Vega, Jose Velazquez et al. (2018) Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways. NPJ Precis Oncol 2:24
Ferris, Matthew J; Liu, Yuan; Ao, Jingning et al. (2018) The addition of chemotherapy in the definitive management of high risk prostate cancer. Urol Oncol 36:475-487
Halicek, Martin; Little, James V; Wang, Xu et al. (2018) Deformable Registration of Histological Cancer Margins to Gross Hyperspectral Images using Demons. Proc SPIE Int Soc Opt Eng 10581:
Cassidy, Richard J; Switchenko, Jeffrey M; El-Deiry, Mark W et al. (2018) Disparities in Postoperative Therapy for Salivary Gland Adenoid Cystic Carcinomas. Laryngoscope :

Showing the most recent 10 out of 331 publications